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aCPR: Advanced Cardiopulmonary resuscitation.  
CA: Cardiac Arrest 
CPR: Cardiopulmonary resuscitation.  
DBD: Donation /Donor after Brain Death.  
cDCD:Controlled Donation/ Donor after Circulatory Death 
DCD: Donation/ Donor after Circulatory Death 
DGF: Delayed Graft Function.  
DTC: Donor Transplant Coordinator 
EMS: Emergency Medical Service 
hRP: Hypothermic regional perfusion.  
nRP: Normothermic regional perfusion.  
ISP: In situ preservation.  
PNF: Primary non function.  
uDCD: Uncontrolled Donation/ Donor after Circulatory Death 








I. INTRODUCTION / BACKGROUND 
 
 
Shortage of organs has made a global interest for donation after circulatory death (DCD) to re-emerge. 
While controlled DCD (cDCD) has been progressively increasing, uncontrolled DCD (uDCD) has only been 
developed in a few settings.1 This activity is quantitatively important in France and Spain, although it has 
also been reported in other European countries, as Austria, Belgium, Italy, the Netherlands, and recently in 
Russia.2,3 uDCD protocols have allowed the transplantation of a significant number of kidneys, livers and 
lungs at these countries.3 Excellent graft survival has been reported in kidney transplantation from uDCD, in 
spite of an increased incidence of delayed graft function (DGF).4,5,6,7,8,9,10,11,12,13,14,1516 Albeit promising, results 
with liver transplants obtained in uDCD protocols do not consistently provide similar outcomes compared 
with livers from donors after brain death (DBD), mainly due to a higher incidence of primary graft dysfunction 
and non-function and biliary complications.17,18,19,20,21,22 Lung transplantation is still facing limited experience, 
but preliminary results are encouraging.23,24,25   
 
The development of uDCD does not only rely on technical knowledge and skills, but on important 
organizational efforts for a time-dependent process to be activated once the opportunity of donation is 
identified. This opportunity is represented by persons who suffer an unexpected and witnessed cardiac 
arrest (CA) and in whom advanced cardiopulmonary resuscitation (aCPR) has been exhausted, and resulted 
unsuccessful. The complexity of the process to follow - with protocols designed to minimize the duration and 
the impact of warm ischemia time (WIT)- may be fairly represented by the limited effectiveness of these 
programmes, in terms of the potential donors finally converted into actual donors.18,22 The figures available 
also describe that only about 65% of actual donors become utilized donors and that the number of organs 
transplanted per donor is below 1.5 in France or Spain.2  
 
The potential of uDCD in the United States has been estimated to be of up to 22,000 a year.26 Based on the 
availability of air ambulance teams and cases of witnessed CA transferred to the hospital during a 75 month 
period, uDCD was estimated to yield 300 potential donors per year in England and Wales.27 However, uDCD 
has remained confined within a few countries. Besides the technical and organizational difficulties, ethical 
dilemmas have been posed as other reasons for this constraint activity and have been the main difficulty 
encountered when trying to emulate this practice.28,29,30  
 
The objectives of this paper were: a) to describe consolidated uDCD programmes in Europe, including 
information on the underlying regulatory and ethical frameworks and on organizational and technical 




A dedicated questionnaire was developed to collect information on the regulatory and ethical framework and 
the practice of uDCD in the European countries with the highest activity- France and Spain- and on the 
Dutch programme. Topics addressed were: a) general information; b) donor selection criteria; c) logistics of 
the protocol (out-of-hospital and in-hospital); d) determination of death; e) consent and authorization; and f) 
preservation. Information was obtained from the national transplant agencies (Agence de la Biomedecine- 
France, Dutch Transplant Foundation- the Netherlands, Organización Nacional de Trasplantes- Spain) and 
experts in the field.  
 
An electronic search was performed in Medline and Pubmed, Cochrane library, ClinicalTrials.gov, and 
ControlledTrials.com. Keywords used: [‘Cardiac arrest’ or ‘’Uncontrolled’] and [‘’Non Heart Beating Donation’ 
or ‘Donation after Circulatory Death’ or ‘Donation after Cardiac Death’]. Articles written in English, French 
and Spanish were selected. Abstracts were first reviewed. If the article was identified as discussing key 
regulatory-ethical issues or describing logistic aspects of uDCD, then the manuscript was further reviewed 





Recommendations were built based on the available evidence. Where possible, articles were ranked and 
recommendations graded as specified by the Oxford Centre for Evidence-based-Medicine (www.cebm.net/). 
Recommendations on ethical aspects resulted from a deliberative approach among participants and 
consensus.  
 
III. ETHICAL-REGULATORY FRAMEWORKS, PRACTICES AND EVIDENCE 
 
1. General information 
uDCD first started in Maastricht, the Netherlands, in 1981. The first procedures in Spain were described in 
the 80s. The programme started in 2006 in France. The number of active programmes in 2011 was 9 in 
France and Spain, and 4 in the Netherlands, with a number of actual uDCDs of 58, 112 and 1, respectively. 
Of note, more than 90% of these donors were persons who had suffered the CA in the out-of-hospital 
environment.  
 
France, the Netherlands and Spain have specific legislation providing the framework for the practice of 
uDCD. The legal texts include provisions related to criteria for the determination of death, limitations to 
preservation –if any- and the consent to organ preservation-recovery, among others. In the three countries, 
national protocols/recommendations/guidelines have been issued, that deal with the ethical, technical 
and organizational aspects of uDCD.31,32,33,34 Dedicated action protocols defining roles and 
responsibilities in the process are in place at every Extrahospital Emergency Service (EMS) and 
hospital embarked on this type of donation. These protocols are adapted to the available material 
and human resources and the internal organization of the corresponding service and hospital.   
 
The process of uDCD includes a number of phases, not necessarily sequential, graphically represented in 
figure 1. The practice of uDCD in the three studied countries, along with the available evidence, and their 
position with regards to some of the dilemmas that may arise at each of the phases are detailed below. 
Reducing WIT and its potential impact as to ensure organ viability and optimal postransplant results is the 
underlying principle guiding the said practice, while respecting ethical standards, and ensuring the quality 
and safety of the procedure.  
 
2.  Donor identification and referral 
The uDCD process is activated when a potential donor is identified, i.e., a person who fulfils all the criteria 
below:  
 
 has suffered a witnessed CA, in the out-of-hospital or in the in-hospital setting;  
 aCPR has been exhausted, according to national protocols, aligned with international 
professional standards35,36;   
 aCPR has been deemed unsuccessful by the attending team; 
 a set of selection criteria is met, in terms of age, co-morbidities, circumstances of 
CA and WIT. A summary of the selection criteria applied in the evaluated programmes is 
shown in table 1.  
 
With regards to persons in whom CA has occurred in the out-of-hospital setting, only persons who are 
transferred to the hospital with a therapeutic purpose and in whom aCPR is considered 
unsuccessful within the hospital are considered potential uDCDs in the Netherlands. In France and 
Spain, also persons in whom aCPR is deemed unsuccessful in the pre-hospital setting by 
medicalized EMS can be considered potential uDCDs and transferred to the hospital with that 
purpose.  
   





1.1.1. Unsuccessful CPR 
 
CA is considered irreversible based on international standards if, despite aCPR being carried out correctly 
and without interruption for at least 30 minutes, return of spontaneous circulation is not achieved and the 
patient shows clinical signs of death -lack of consciousness and spontaneous movements, absence of 
spontaneous breathing, no detectable blood pressure, pulse or cardiac sounds-.35,36 In some circumstances, 
as pre-arrest hypothermia, suspected poisoning or metabolic derangement, CPR has to be prolonged and 
additional therapeutic options have to be considered, based on the mentioned standards.  
 
1.1.2. Donor age  
Most of the existing uDCD programmes have restriction criteria on age, but there is no strong 
evidence for age cut-offs. In a series of 242 kidney transplants, Mizutani et al reported lower graft survival 
for recipients of kidneys aged >60 years compared with the younger uDCD group.5 This result was confirmed 
by Hattori et al who, in a retrospective study of 706 kidney transplants from uDCDs, reported that donor age 
>55 years had a negative impact on long-term graft survival.6 In one of the largest series published, 
Sánchez-Fructuoso described that 1 and 5 year graft survival for kidneys from uDCDs with a maximum 
donor age of 60 years was similar to that of kidneys from DBDs <60 and significantly better than that of 
kidneys from DBDs ≥60 years.8 More recently, donor age ≥54 years was identified as a risk factor for primary 
non function (PNF) and decreased graft survival in a series of 135 kidneys from uDCDs.15 Based on these 
limited data, it appears appropriate to include in uDCD programmes young subjects ≤55-60 years, 
although some of the existing programmes are transplanting kidneys beyond this age cut-off value 
(Table 2).  
 
1.1.3. Comorbidities 
Some of the existing programmes exclude patients with a history of arterial hypertension or diabetes even 
if these diseases are controlled, kidney/liver diseases, some brain tumours or cancer. Sepsis, viral infection 
(HIV, HBV, HCV) and intravenous drug abuse are also contraindications for uDCD. 
 
1.1.4. Circumstances of death 
Suicide and homicide are contraindications for uDCD in some of the existing programmes, because of 
potential judicial obstacles. Major trauma is also a contraindication due to the risk of organ damage and 
hypoxia in case of haemorrhage. However, abdominal trauma does not preclude lung donation.  
 
1.1.5. Warm ischemia time  
Minimization of WIT is a critical factor. uDCD programmes in France and Spain recommend that a) the no 
flow period is <15-30 minutes for kidney and <15 minutes for liver; b) total WIT is <150 minutes.31,34 However, 
these recommendations are based on empirical grounds and require of further research and 
validation. 
 
1.2. Donor referral 
Communication of a possible uDCD to a pre-specified hospital implies the transmission of a minimum set of 
information to ensure selection criteria are met, and to activate and facilitate the transfer to the 
corresponding hospital or ward. An example of the list of items covered in this communication is shown in 
table 3. The identification and subsequent referral of the potential donor is necessarily performed by the 
team in charge of the aCPR. Different procedures are used for the communication, either through an 
intermediate and/or directly through radio or phone.  
 
The effective referral of the potential donor requires of the availability of a Donor Transplant 
Coordinator (DTC) at the hospital, this being the case at the three studied countries. The DTC is 24/7 




The DTC is in charge of: a) evaluating the referred potential donor, ensuring that selection criteria are met; 
b) authorizing the transfer to the hospital; c) alerting a first rapid team of professionals in charge of 
completing the evaluation, obtaining consent/authorization and initiating the preservation measures, and a 
second team in charge of organ recovery, arriving at a later stage; d) locating relatives, if not present at the 
scene of the CA, in cooperation with the relevant agencies, as appropriate.  
 
 
3. Donor transfer 
The transfer of a potential donor to the corresponding hospital/ward implies maintaining cardiac 
compression and mechanical ventilation as per CPR standards35,36, but for the purpose of preserving 
organ viability, since aCPR has already been deemed unsuccessful and hence further care is 
considered futile.  
 
The majority of the existing programmes use mechanical cardiac compression devices for donor 
transfer, although there is limited evidence on its superiority vs. manual cardiac compression in 
terms of organ viability and postransplant outcomes. Preliminary results of the CIRC Trial show that 
return of spontaneous circulation and survival at hospital discharge for patients with a pre-hospital CA is 
similar with the use of Autopulse® compared with high-quality manual CPR.37 A similar randomized 
controlled trial is being conducted with LUCAS2®.38 The use of mechanical devices also facilitates long-
distance transportation with good quality cardiac compression.39,40 From the above, it could be derived 
that organ viability would be better preserved with mechanical devices. However, this is not 
consistently concluded from the available evidence. In a cohort study comparing the results of an uDCD 
programme with donor transfer performed with the LUCAS® device (n=91) vs. manual cardiac compression 
(n=112), the former was associated with a significant decrease in the number of kidneys discarded because 
of inappropriate organ perfusion (32.9% vs. 56.6%; p=0.026) (3b-4).41 Nonetheless, in another observational 
study, assessing the outcome of kidney transplants (n=39) from uDCD under mechanical vs. manual chest 
compression, the incidence of PNF was similar (5.1% vs. 9.1%; p=0.5) (3b-4).42 Data from a cohort of 50 
uDCD also showed similar renal function at 6 and 12 months in kidney transplants from donors transferred 
with mechanical devices vs. manual chest compression (3b-4).43  
 
On the other hand, it has been suggested that the use of mechanical devices for cardiac compression may 
cause lung injuries that could invalidate these organs for transplantation. This is not confirmed in dedicated 
studies comparing the LUCAS® device with manual chest compressions for the treatment of CA.44,45 
Moreover, a recent series of 33 potential uDCDs under mechanical cardiac compression showed a limited 
number of mild and no severe thoracic and lung injuries, assessed by chest X-ray, tracheal and nasogastric 
tube examination and bronchoscopy (4).46  
  
The transfer of a potential uDCD from the out-of-hospital setting needs of a slow and constant speed 
of the corresponding vehicle to ensure an appropriate cardiac compression and an adequate 
perfusion of the organs. The transfer may be facilitated by the intervention of other agencies. In many 
occasions, the presence of the police is required. In addition, as in the transfer of critically ill patients, the 
use of security forces to regulate the traffic is common in order to avoid hemodynamic changes secondary 
to braking and acceleration. It is desirable that these agencies are familiar with the uDCD protocol.  
 
4. Determination of death 
Determination of death in current uDCD programmes takes systematically place in the in-hospital setting. 
Criteria are unanimous at the three evaluated countries:  
 
 aCPR exhausted according to national protocols, aligned with international 
standards, and deemed unsuccessful is a pre-requisite. aCPR is identically applied, 
regardless of whether the person could be considered a potential donor or not. 
 Cessation of circulation and respiration is assessed based on the absence of 




echocardiography or invasive blood pressure measurement) in case of electro-mechanical 
dissociation – if all its reversible causes have been discarded and treated.  
 Irreversibility of the cessation of circulation (and respiration) is established after a 
minimum observation period of 5 minutes.  
 
In France and Spain, determination of death preceding uDCD is based on the actual and demonstrated 
irreversibility of circulation, because aCPR has been exhausted and deemed unsuccessful, according to 
existing international standards and end-of-resuscitation rules.35,36,47 Based on this irreversibility concept, it 
would be arguable if an observation period is needed, although both countries respect a 5 minutes no-touch 
period. The possibility of an unperceived auto-resuscitation during donor transfer (after CPR has been 
deemed unsuccessful, but before determining death) is impossible the way protocols have been conceived. 
Potential donors remain monitored electrocardiographically during transfer, a period in which cardiac 
compression and mechanical ventilation are extended beyond the point of irreversibility of the CA, for the 
purpose of organ preservation. Because circulatory function is considered to have ceased irreversibly, the 
re-establishment of circulation after death with the aim of organ perfusion is considered ethically appropriate 
and is legally permitted and systematically performed at these two countries. These criteria for the 
determination of death are in contrast with standards developed in countries primarily focused on cDCD, 
where the permanent cessation of circulation (‘will not return’) is used as a surrogate of the irreversible 
cessation of circulation (‘cannot return’) for the diagnosis of death.48,49,50,51 In the views of countries with 
consolidated uDCD programmes and other commentators, the permanent cessation of circulation should 
not be the criteria applied to the determination of death under these very particular circumstances. These 
different approaches are however a matter of international debate. 52,53,54,55,56 
 
Death by circulatory criteria in the three described programmes is systematically certified by a 
professional(s) independent of the donation and transplantation activity, in particular, by the team taking 
over the aCPR manoeuvres for cases transferred from the out-of-hospital setting and by the team in charge 
of the aCPR when CA has occurred within the hospital- usually intensive or emergency care professionals. 
The fact that a new evaluation of the irreversibility of the CA and death determination is performed 
by professionals independent from those who attended the CA in the pre-hospital setting is 




After death is determined and certified, cardiac compression and mechanical ventilation is re-
established routinely in France and Spain, with the purpose of organ preservation, this not being 
the case in the Netherlands. No dedicated studies have compared the results of re-establishing vs. 
not re-establishing cardiac compression until further preservation measures are initiated. However, 
the most consolidated uDCD programmes in terms of number of actual and utilized donors, and 
organs recovered and transplanted apply cardiac compression systematically after death. These 
programmes also offer the most promising results with regards to postransplant outcomes, not only 
in kidney, but also in liver transplantation. (Table 4 and 5).  
 
5.1. Preservation of abdominal organs 
 
Preservation of abdominal organs is usually performed through hypothermic regional perfusion 
(hRP) or normothermic regional perfusion (nRP) in France and Spain, although in situ preservation 
(ISP) is also applied in some programmes just with the aim of kidney preservation. Of note, 
preservation with hRP/nRP in uDCD is a legal requirement for further proceeding with liver 
transplantation in France. Table 6 summarizes the main aspects of the different techniques. 
 
There are variations in the maximum WIT allowed (usually 150 minutes). In the Netherlands, where cardiac 
compression is not restored after death, there is an additional no flow period following death allowed to be 




preservation measures, before proceeding with organ recovery, but most of the programmes establish the 
limit of 240 minutes in case of hRP/nRP, with more restrictive times for ISP. Maximum WIT and preservation 
times allowed in the three programmes are graphically represented in figure 2. These maximum times are 
however based on empirical grounds.  
 
Tables 4 and 5 show the results of kidney and liver transplantation in uDCD with different preservation 
strategies. In the setting of kidney transplantation, there is only one study directly comparing the three 
different techniques. Valero et al observed that the incidence of DGF and PNF was significantly lower when 
preservation was based on nRP (n=8) vs. hRP(n=8) and ISP (n=44) (p<0.01).57 Also, duration of DGF was 
significantly shorter with the use of nRP compared with ISP (p<0.05). 
 
In the field of liver transplantation from uDCD, the early results published by the Pittsburgh group in 1995 
were disappointing, with very poor graft and patient survival in a series of 6 cases.58 In 2003, a higher graft 
and recipient survival were reported in a Spanish series of 20 liver recipients from uDCD, with a 
heterogeneous use of preservation methods (chest-abdominal compression-decompression vs. hRP vs. 
nRP).20 A subsequent description of 10 liver transplants whose donors had been only subjected to chest-
abdominal compression-decompression, raised survival to 90% after 57 months of follow-up.21 Later on, the 
use of nRP preceded by chest compressions by experienced centres has been related to optimal results in 
the short-term. Using this approach, in a prospective case-control study comparing liver transplantation from 
uDCD (n=20) vs. DBD (n=40), 1 year graft and patient survival was 80% and 85.5% vs. 87.5% and 87.5%, 
respectively. Although the incidence of PNF and ischemic cholagiopathy was higher in the uDCD group, the 
difference was not statistically significant.22 Combining chest compression with the LUCAS2® device after 
death determination with nRP, Fondevila et al. reported the results of a series of 34 liver transplants from 
uDCD with one 1 year graft and patient survival of 70% and 82%, respectively.18  
 
The superiority of nRP can be explained by the fact that re-establishing warm oxygenated reperfusion allows 
some repair for WIT to take place – something supported by experimental studies59,60,61 and provides a 
period for a better biochemical assessment of the liver – and hence a more appropriate selection of the liver 
donor. It is worth noting however that preservation with hRP/nRP has also been related to technical 
difficulties that may derive in potential donor losses. The Barcelona group reported that out of 400 potential 
uDCD placed under nRP, 72 (18%) were discarded due to inadequate venous return, resulting from 
unrecognized vascular trauma or internal haemorrhage or supposedly from the collapse of the inferior cava 
vein.18  
 
Recently, a novel preservation approach for abdominal organs in uDCD has been described in San 
Petersburg, Russia.3 The protocol is applied to patients suffering an in-hospital CA unsuccessfully 
resuscitated. After death is determined, heparine is administered and distributed through the application of 
a limited number of cardiac compressions. This is followed by a no flow period of up to 90 minutes, when 
preservation of abdominal organs starts with nRP, combined with leukocyte depletion and fibrinolytics. 
Results with the transplantation of 20 kidneys from 10 uDCD show a 100% 3 month graft survival. These 
promising data may be guiding future preservation approaches in uDCD that allow longer acceptable WIT– 
something invaluable for overcoming key obstacles, as determination of death and consent. 
 
5.2. Lung preservation   
Lung recovery is about to start in France and the Netherlands. In Spain, the recovery of lungs is 
systematically performed in some of the uDCD programmes. Lungs are the only organs not requiring 
circulation to maintain the aerobic cellular metabolism, due to the mechanism of passive diffusion across 
the alveolar membrane. It has been shown an adequate gas exchange even after 2 hours of WIT in the 
absence of lung circulation, which could be extended to 4 hours in case of heparinization. The best method 
for the preservation of non-ventilated lungs is topic cooling.  
 
After mechanical ventilation is interrupted and the preservation of abdominal organs has been started, where 
appropriate, bilateral thoracic drains are placed via transthoracic insertion, through the second intercostal 




allow for a topic cooling and lung collapse. Oesophageal temperature is maintained at 20ºC.23,24 In case of 
abdominal preservation with nRP or to better ensure the cooling of the lungs, some groups place a system 
for the recirculation of the lung preservation solution, to keep this target temperature. For such purpose, two 
additional thoracic drains are placed in the sixth intercostal space, midaxilar line.62 However, the usefulness 
of this approach has not been shown yet. Before the procedure is started, approximately 300 mL of venous 
blood from the potential donor are recovered and preserved at 4ºC for the ulterior functional evaluation of 
the lung. The maximum preservation time varies according to the team, but – based on empirical grounds – 
the usual criteria applied is 240 minutes.31,32,34 
 
6. Donor evaluation 
Donor evaluation is a continuum which already starts in the phase of donor identification. In uDCD, inclusion 
and exclusion criteria are similar to those applied in DBD, with some peculiarities, as specified in section 
1.1.   
 
As for a DBD, donor and organ evaluation are based on the review of the past and present medical history 
and risk behaviours of the potential uDCD, a physical examination and complementary tests. Available 
medical records and charts must be carefully reviewed. A dedicated and guided interview with the relatives 
always should take place for the assessment of donor´s suitability.  
 
Donor evaluation can be facilitated by the EMS in several ways. Usually, blood samples are taken once 
death has been determined. Of note, potential uDCD are frequently haemodyluted when CA occurs in the 
pre-hospital setting and has been followed by the transfer to the hospital. To ensure that non haemodyluted 
samples are available for a proper donor evaluation, e.g. serology, some Spanish programmes have 
incorporated to the EMS protocol the recovery of blood samples once the uDCD procedure is activated. 
These early samples are also of value when potential donors have exsanguinating lesions, preserving the 
option of lung donation. On the other hand, some EMS are able to discard potential uDCD at the scene of 
the CA through using rapid drug tests and strip-based HIV testing. This practice avoids the unnecessary 
activation of the protocol and the related use of resources.  
 
7. Consent and authorization for organ donation 
Consent to proceed with organ donation is assessed differently in the three evaluated countries, based on 
the dissimilar practicalities of uDCD and legislation, particularly when the potential uDCD suffers the CA in 
the out-of-hospital setting.  
 
With an opt-in system, the practice in the Netherlands is to assess if the person has expressed his/her will 
about organ donation after death. A national registry must be consulted by the DTC or emergency room 
staff to assess the person´s wishes. Even in the case of an expressed consent in the said registry, a 
dedicated interview is held with the relatives before proceeding with organ recovery. In the uDCD process, 
the registry may be consulted as early as when the EMS announces that a potential donor is being 
transferred to the hospital. In case of registered opposition, the process is not continued. If no opposition 
towards donation or positive consent is identified, it is allowed by the national Law to start with preservation 
measures after death. However, this is not continued with organ recovery if the family oppose or if the family 
interview cannot be held within the first 2 hours following the initiation of the preservation measures.  
 
France and Spain hold an opting-out policy, so obtaining consent is focused on checking any expressed 
opposition towards donation during lifetime- there is a specific national registry in France, and an advanced 
directives registry in Spain. In both countries though an interview with the relatives is held. However, 
facilitating donation until opposition is encountered is eased by the existing legal framework. In this context, 
consent may be obtained at different time points along the process: as soon as when the irreversibility of 
the CA is established by the EMS, or until preservation measures have started. In France, checking the 
donor registry is mandatory before preservation is initiated, but not in Spain. Organ recovery will never 





Principles guiding the information to relatives in uDCD have been a matter of international debate. 
The three countries hold transparency in information as a paramount principle. Messages are 
provided progressively and adapted to the emotional situation of the relatives and their 
understanding of the situation. Particular emphasis must be performed on cases transferred to the 
hospital for the purpose of organ donation. 
 
With regards to the judicial authorization procedure, specific protocols are in place in Spain to facilitate a 
rapid communication with the coroner and a rapid authorization, first for preservation and later on for organ 
recovery. Although in principle limited to judicial cases, in practice, these protocols are applied in most of 
the cases with a prehospital CA. The reason is that frequently professionals in charge of determining death 
lack of the necessary information to specify the cause of the CA, further to be determined through a judicial 
autopsy.  
 
8. Resources of EMS and uncontrolled DCD 
In the experience of existing programmes, the implementation of uDCD does not entail an increase in 
material or human resources on the EMS side. As for any time-dependent process, the essentials are a 
dedicated action protocol that reduces variability and ensures quality in practice, the smooth coordination 
and communication with the receiving hospital and the fast transfer of the potential donor. Table 7 
summarizes three levels of participation of an EMS in uDCD based on the availability of resources.  
 
For a basic implementation of the programme, additional means to those already available at any EMS 
are not necessary, since all are equipped with material for advanced-life-support. Additional resources 
may however facilitate the selection and evaluation of potential donors, avoiding unnecessary activations of 
the protocol if contraindications to donation are already identified at the scene.  
  
As previously specified, the use of mechanical cardiac compressors can facilitate the transfer of potential 
uDCD and the safety of those in charge of cardiac compression, but it is not an essential. The use of rapid 
screening tests for certain diseases (e.g. HIV,) and drugs, helps to a better early selection of the cases.  
 
If possible within the organization of the EMS, the presence of another vehicle can be very useful for 
enabling logistic support and helping in the cardiac compression and mechanical ventilation measures.  
When is not feasible to transfer potential uDCD by road, the use of helicopters is a possible solution63. This 
allows expanding the pool of potential donors, by including those from areas with a complicated orography 
or with a long distance from the receiving hospital. 
 
With regards to additional human resources at the scene, the presence of a senior professional who 
coordinates all external and internal participants and guarantees the adequate compliance with the operating 
procedure may be considered. This figure may help to ensure a quality control in the compliance with the 
procedure. The presence of a psychologist at the scene may be useful for the information and to assist 
and accompany the family until the hospital.  
 
Finally, the composition of the EMS teams may be critical. The presence of physicians at the scene of the 
CA does not only improve the quality of assistance, but also facilitates this particular donation process- the 
existence of medicalized EMS may be one of the underlying reasons for the important expansion of uDCD 









1. uDCD is a necessary practice in the pursuit of self-sufficiency in transplantation, 
in particular, in maximizing donation from the deceased. It represents the 
culmination of systematically placing donation at the end-of-life in all possible 
circumstances of death. Efforts must be undertaken to overcome the ethical, 
legal, technical & logistical barriers that avoid uDCD to be possible at the 
European level and at each Member State reality. (Expert opinion)  
2. uDCD needs vision, dedication and institutional support. An unambiguous 
national regulatory framework should exist to facilitate uDCD and its time 
constrained related-practice. (Expert opinion)  
 
Regulatory aspects should cover, at a minimum, issues related to:  
 Determination of Death – criteria to define the cessation of the cardiac-circulatory 
(and respiratory) functions and when such cessation is to be considered 
irreversible, along with the pre-conditions for the determination of death – aCPR 
applied and optimized as specified in national CPR protocols, aligned with 
international professional standards. 
 Preservation measures – establishing any limitations to its practice, if deemed 
appropriate within a given jurisdiction.   
 Consent and authorization criteria to proceed with organ preservation and 




3. Respectful with the national regulatory framework, a specific action protocol 
should be established at every EMS and hospital engaged in an uDCD 
programme, where roles and responsibilities are clearly defined, and which is 
adapted to the available human and material resources and to the internal 
organization of the corresponding service. (Expert opinion). 
 
A dedicated protocol sets the basis for consistency in the development of the process, 
avoiding personal interpretations, and ensuring quality in practice. This protocol should 
be developed by a multidisciplinary team with the representation of all relevant 
professional groups engaged – in smooth cooperation with the EMS, where appropriate-
. The protocol should be continuously reviewed, updated and subjected to quality control. 
Continuous training and education, as well as information on the results of the 
implementation of the protocol should be provided periodically to all relevant stakeholders 
and professional groups directly or indirectly participating in the development of the 
uDCD activity.  
 
4. uDCD will only be considered in persons who have suffered a witnessed and 
appropriately documented CA (either in the pre-hospital or in the in-hospital 
setting) and in whom CPR has been exhausted according to national protocols, 
aligned with international standards, and deemed unsuccessful by the attending 






5. Selection criteria for uDCD represent an important area for research in the future, 
particularly with regards to the limits in donor age and in WIT, which have been 
established based on empirical grounds. The following set of criteria describes 
the current practice in most of the existing programmes and may be proposed as 
the recommended profile (Recommendation grade C):  
 
 Time of CA known 
 ≤55-60 years  
 No evidence of : 
 Arterial hypertension – relative contraindication for kidney.  
 Diabetes – relative contraindication for kidney 
 Kidney disease 
 Liver disease 
 Malignancies  
 Intravenous drug abuse 
 Sepsis and viral infection (HIV, HBV, HCV) 
 No major trauma – relative contraindication- abdominal trauma 
does not preclude lung donation.  
 No homicide or suicide – relative contraindication.  
 Time between CA and CPR initiation (no flow period) <15-30 min for 
kidney transplants, <15 min for liver transplants. 
 Total WIT <150 min. 
6. A mechanism for the activation of the uDCD protocol by the team in charge of the 
CPR should be enabled. (Expert opinion). 
 
Smooth communication between the attending team and the receiving hospital is 
paramount.   
 
 
7. A key donation person / DTC should be 24/7 present at the relevant hospital or be 
able to reach the hospital at a maximum time of 20 minutes. (Expert opinion). 
 
In case of programmes that may be activated by the EMS, the DTC should be checking 
the selection criteria and authorizing the potential uDCD transfer, where appropriate, and 
should be always present at the arrival of the potential uDCD at the hospital. In every 
single case, the activation of a rapid alert team and the transplantation team should 
follow. In checking the selection criteria, special emphasis should be performed in the 
WIT (time since CA until the initiation of aCPR and estimated time of initiation of the 
preservation measures).  
 
 
8. As for the purpose of the transfer of the potential uDCD, mechanical cardiac 
compressors are not essential, although its use improves the quality of cardiac 
compression and the safety of participating professionals and may improve organ 






9. The transfer of a potential uDCD from the out-of-hospital setting needs of a slow 
and constant speed of the corresponding vehicle to ensure an appropriate cardiac 
compression and an adequate perfusion of the organs (Recommendation grade 
C).  
 
An appropriate transfer may be facilitated by the coordination with other agencies. 
10. Death determination should always be the responsibility of a professional(s) 
independent of the donation and transplantation team (Expert opinion). Death 
determination preceding uDCD is based on the irreversible cessation of cardiac-
circulatory and respiratory functions. (As per international recommendations on 
CPR- Recommendation grade A). 
 
 The cessation of the cardiac-circulatory function should be based on the 
absence of electrical activity by ECG or the appropriate means (as 
echocardiography or invasive blood pressure measurement) in case of electro-
mechanical dissociation, when reversible causes have been discarded and 
treated.  
 
 The irreversibility of the loss of circulation is derived from the inability to 
restore spontaneous cardiac activity and circulation after aCPR has been 
applied and fully optimized according to national protocols, aligned with 
international standards. Still, an observation period is recommended to 
be set down as a minimum in 5 minutes. There is no solid basis to 
recommend extending this period of observation beyond this time.  
 
11. There is a need to review some of the already existing national standards on the 
determination of death based on circulatory criteria, by also capturing the clinical 
specificities of uDCD.  (Expert opinion). 
 
There is controversy with regards to the validity of death determination after the re-
establishment of systemic (and cerebral) circulation with oxygenated blood. In the 
context of uDCD, this controversy is unfounded in the long lasting experience of 
consolidated programmes due to the particular clinical characteristics of potential 
donors. Firstly, the permanent cessation of circulation as a surrogate of the irreversible 
cessation of circulation is not applicable in this setting- because irreversibility has been 
already proven. Secondly, because potential uDCD have been exposed to prolonged 
low-flow periods (aCPR and cardiac compression during donor transfer) and to at least 
two periods of complete absence of circulation, with previous aCPR deemed 
unsuccessful by the attending team. The possibility of restoring brain function following 
the re-establishment of circulation is expected to be clinically negligible due to the 
profound ischemic injury to the brain. The applicability of the permanent cessation of 
circulation as a surrogate of the irreversible cessation of circulation in uDCD is not 
accepted in countries with consolidated programmes of this kind, which base the 
determination of death on the irreversible loss of cardiac-circulatory functions.  
 
 
12. Although the practice of re-establishing systemic circulation with cardiac 
compression after death is determined with the purpose of organ preservation is 
not applied in all existing programmes, this practice is considered to profoundly 
impact organ viability and post-transplant outcomes – especially for liver-, a 
conclusion that may also be derived from the results of the most successful uDCD 




13. The effectiveness of the different preservation procedures for abdominal organs 
in the context of DCD, and in the context of uDCD in particular, is still to be 
compared in randomized controlled trials. However, preclinical and cohort studies 
suggest the superiority of nRP, compared to hRP, and that of hRP compared with 
ISP in kidney transplantation and makes nRP (preceded by cardiac compression) 
to be the advisable preservation method for the liver. (Recommendation grade C).  
 
However, ISP may be considered as an option in kidney transplantation, as long as 
stricter criteria are used in donor selection –e.g. age and WIT .Additionally, the non-
realization of the uDCD process when hRP/nRP is used is a matter of concern. 
The possibility of converting the preservation procedure to ISP in cases where 
the former fails may be seen as an option, e.g. when the integrity of the vascular 
structure is not ensured.  
 
Research is needed for the objective establishment of the maximum times for 
abdominal preservation techniques, but current protocols establish the limit of 180 min 
for ISP and 240 min for RP. The role of leukoapheresis combined with nRP is to be 
determined. Each programme should select the preservation method that is better 
adapted to the local reality and resource availably, but the principles of reducing 
potential donor losses as much as possible, while ensuring organ viability and optimal 
postransplant results are paramount.  
 
 
14. Preservation of the lungs should be based on topic cooling. The recirculation of the 
lung preservation solution allows for the simultaneous normothermia for abdominal 
organs. Further research should help establish the maximum times for 
preservation in terms of organ viability and postransplant outcomes, but existing 
programmes set down the limit of 240 minutes. (Recommendation grade C).   
15. Donor evaluation is based on the same principles than the evaluation of any 
deceased organ donor. As for a DBD, donor and organ evaluation is based on the 
review of the past and present medical history and risk behaviors of the potential 
uDCD, a physical examination and complementary tests. Available medical 
records and charts should be carefully reviewed and a dedicated and guided 
interview with the relatives should always take place for the assessment of 
donor´s suitability. (Expert opinion). 
 
 
16. For potential uDCD in whom CA takes place in the pre-hospital scenario, donor 
evaluation can be facilitated by the EMS in several ways, particularly through the 
collection of blood samples (avoiding potential donor losses due to 
haemodylution or  exanguination- lung transplantation still possible) or the 
performance of dedicated screening tests at the scene (ie. HIV rapid strip test). 
(Expert opinion). 
17. Information to the relatives and the procedure for obtaining consent to proceed 
with organ preservation and organ recovery should be respectful with the consent 
system in place at a given jurisdiction. The principle of transparency should be 







18. A dedicated judicial procedure should be enabled for judicial cases due to the 
time constraints of the process. (Expert opinion). 
 
 
19. An EMS fully implemented in society does not need any additional equipment for 
the development of uDCD. The essentials are a clear protocol and a smooth 
































Table 1: Selection criteria of uncontrolled donors after circulatory death in France, the Netherlands and 
Spain.  
 
aCPR: Advanced Cardiopulmonary Resuscitation.  
 France Netherlands Spain 
Age (Min-Max), years 18-55  12-65 Min: 1 –18; Max: 55-65 
Weight (Min), Kgs No limit One programme excludes  
cases <12 Kg. 
One programme excludes <15 
Kg and other programme 
excludes morbid obesity 
Cause of Cardiac Arrest  Excluded cardiac arrest due to 
hypothermia or cardiotropes 
(aCPR has to be prolongued) 
and violent deaths (eventual 
legal problems). 
 
No limit. Violent deaths excluded in some 
programmes.   
Time of cardiac arrest, before 
aCPR is started  
< 30 min for kidney / < 15 min 
for liver. 
< 20 minutes . < 15 -20 min (depends on the 
programme). 
External aspect  Excluded cases with signs of 
intravenous drug addiction. 
Excluded cases with signs of 
intravenous drug addiction. 
Excluded cases with signs of 
intravenous drug addiction. 
Traumatism Excluded multiple trauma with 
hemorrhagic shock, kidney and 
liver injuries and aortic 
dissection  
Excluded hemorrhagic shock 
or aorta dissection. 
Excluded exsanguinating lesions 
in thorax or abdomen, since they 
may avoid an appropriate 
oxygenation and preservation. 
Time goal until arrival into the 
hospital 
120 min 90 min 90 min (120 min in one 
programme). 
Other (Please, specify) For kidney, exclusion criteria 
are renal disease, arterial 
hypertension or diabetes even if 
treated, all cancer types, severe 
sepsis, violent polytraumatism, 
and homicide.  
For Liver: the 3 first renal 
criteria are replaced by a liver 
disease. 
Maximum mechanical CPR 
(besides 20 min of basic life 
support) of 70 minutes if < 55 
years and 45 minutes if 55-65 
years. 
Unknown cause of death, 
unknown identity, untreated 
sepsis, malignancy, active 
viral infections, active 
tuberculosis. Kidney: primary 
kidney disease 
























*Not specified in the paper, but per protocol.**p<0.05  
CA: Cardiac arrest; DBD: Donors after Brain Death; DGF: Delayed graft function; hRP: Hypothermic Regional Perfusion; ISP: In situ preservation; KTx: Kidney Transplant; PNF: Primary non function; uDCD: Uncontrolled donors after 
circulatory death; WIT: Warm ischemia time; Yr: Years.  
KIDNEY TRANSPLANTATION FROM UNCONTROLLED DCD: RECOMMENDED MAXIMUM POTENTIAL DONOR AGE 55-60 YEARS (GRADE B-C)  
 
Reference Grade Level Study design Trial N W Preservation PNF DGF Graft survival   Patient 
survival 
Hoogland et 





2b Cohort study Identification of risk 
factors for PNF and 
graft survival in KTx 
uDCDs  
135 < 45 min WIT  ISP 22%  
 
35% if donors 
≥54yr vs 16% if < 
54yr** 




















B 2b Cohort study Comparison of 
results of KTx from 
uDCD (maximum 60 
yr)  
vs  








< 15 min no 





























Hattori et al 
(2003), 
Japan6  
C 4 Poor case 
series 
Identification of risk 
factors for graft 
failure in KTx from 
uDCD-  donor age < 





(< 55 yr) 
vs 
192 
(≥ 55 yr) 












B 2b Cohort study KTx from uDCD 
comparing donors < 





































Table 3: List of items to communicate during the referral of a potential uDCD as reflected in the 2012 





Close relatives, availability and information provided 
Timing: 
 Exact time of the cardiac arrest 
 Time aCPR was started 
 Time of transfer to the hospital 
Past and present medical history (if known) 
Cause of the cardiac arrest 
Possible haemorragic lesions 
Venous accesses 
Status of the endotracheal tube (blood, remains) 
Blood gas analysis 
Drug tests, rapid strip HIV test (if tests available) 
ECO Fast (if tests available) 
Use of mechanical cardiac compressor devices 




Table 4: Selected studies addressing preservation strategies and results with kidney transplantation from uncontrolled donors after circulatory death.  
KIDNEY TRANSPLANTATION FROM UNCONTROLLED DCD: nRP PROVIDES SUPERIOR OUTCOMES COMPARED TO hRP AND hRP COMPARED TO ISP, 
PARTICULARLY WITH REGARDS TO THE INCIDENCE OF PRIMARY NON FUNCION (GRADE C) 
Very heterogeneous studies, and only one targeted to study differences in outcomes depending on the preservation method used 
 
Reference Grade Level Study 
design 
Trial N Times In situ 
Preservation 






Utrera et al 
(2013), 
Spain16 
C 4 Case 
series 
Description of 
results of KTx 
from uDCD 
156 - Cardiac 
compression* + 
nRP 




C 4 Case 
series 
Description of 
results of KTx 
from uDCD 
58 <30 min CA-
CPR; <150 min 
total WIT; 
preservation 
time <180 min 
(ISP) or <240 
min (nRP) 
Cardiac 
compression + ISP 
or nRP 




Ex situ kidney 
preservation with 
pulsatile preservation  
De Gracia 
et al (2012), 
Spain13 
C 4 Case 
series 
Description of 
results of KTx 
from uDCD 




ISP or nRP 





Hanf et al 
(2012), 
France14 
B 2b Cohort 
study 
Description  of 
results of KTx 






































used for kidney 
selection in uDCD 
Hoogland 




B 2b Cohort 
study 
Comparison of 
results of KTx 






< 45 min of CPR; 

















used in 82% vs 84% 
Reznik et al 
(2011), 
Russia3 
C 4 Case 
series 
Description of 
results of KTx 
from uDCD 
20 45-92 min no 
flow after 
cessation of CPR 
Leukoapheresis+ 
fibrinolytics + nRP 









B 2b Cohort 
study 
Comparison of 
results of KTx 
from uDCD  
vs  






< 15 min CA-




































et al (2006), 
United 
States7 
B 2b Cohort 
study  
Comparison of 
results of KTx 










Mean: 23.7 min 
CA-Preservation 





- - uDCD are persons with 
an unplanned CA who 
could not be 
resuscitated before 
brain death was 
determined 
Hattori et al 
(2003), 
Japan6  




risk factors for 
graft failure in 
KTx from uDCD-  
donor age < 55  
vs 
























B 2b Cohort 
study 
Comparison of 
results of KTx 
from uDCD <60 
yr  
vs 



































Valero et al 
(2000), 
Spain4 




KTx from uDCD 










<30 min CA-CPR 




































*Not specified in the paper, but per protocol.**p<0.05  
CA: Cardiac arrest; CPR: Cardiopulmonary resuscitation; cDCD: Controlled Donors after Circulatory Death; DBD: Donors after Brain Death; DGF: Delayed graft function; hRP: ECD: Expanded Criteria Donors; Hypothermic Regional 
Perfusion; ISP: In situ preservation; KTx: Kidney Transplant; nRP: Normothermic Regional Perfusion; PNF: Primary non function; SPK: Simultaneous Pancreas Kidney; uDCD: Uncontrolled donors after circulatory death; WIT: Warm 
























*Not specified in the paper, but per protocol. **p<0.05.  CA: Cardiac arrest; DBD: Donation after Brain Death; IC: Ischemia colangiopathy; CPR: Cardio-pulmonary resuscitation; hRP: Hypothermic Regional Perfusion; LTx: Liver 
transplant; NAS: Non anastomotic strictures; nRP: Normothermic Regional Perfusion; uDCD: Uncontrolled Donation after Circulatory Death;  WIT: Warm ischemia time; Yr: years. 
LTx
LIVER TRANSPLANTATION FROM UNCONTROLLED DCD: nRP (PRECEDED BY CARDIAC COMPRESSION) IS ADVISABLE FOR THE PRESERVATION OF LIVERS 
FROM (GRADE C) 
 Grade Level Study 
design 













C 4 Case series Outcomes of LTx from 
uDCD. Compares with 
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uDCD. Comparison with 





























Suárez et al 
(2008), 
Spain19 
C 4 Case series Describe biliary 
complications with LTx 
from uDCD. Compares 
with a large population 



















NAS 25% vs 
2.3%** 
-  
Otero et al 
(2003), 
Spain20 
C 4 Poor case-
control 
study 
Outcomes of LTx from 
uDCD. Comparison with 
with DBD before-after. 
Comparison 
Cardiac/abdominal 






































protocols. Livers on 






Table 6: Technical aspects related to the preservation of abdominal organs in uDCD 
In situ preservation  
 
 Double-balloon-triple-lumen catheter inserted via the femoral artery, one balloon placed at 
the aortoiliac bifurcation and the other balloon placed over the superior mesenteric artery.  
 Drain in femoral vein to allow the clearance of the hematic content,  
 Control of pressure of perfusion of preservation liquid (70-80 mmHg).  
 Variable preservation solutions used (HTK, Wisconsin, Celsior, IGL-1).  
hRP 
 
 Use of an extracorporeal circuit: femoral vessels cannulated and connected with a module 
for temperature exchange and with a membrane oxygenation module: blood is oxygenated 
and cooled at 4-15ºC.  
 The contralateral femoral artery is cannulated with a unique balloon catheter. The balloon is 
advanced into the supraceliac aorta and is inflated with saline and X-ray contrast. Proper 




 Similar to hRP, except for blood maintained at 32-37ºC and kept until the macroscopic 
visualization of liver and kidneys in the surgical room and ulterior cold perfusion with 
preservation solution.  
 Pump flow is maintained at 1.7-2.5 L/min/m2.  
 Blood is sampled at baseline and throughout nRP to determine biochemical and 
haematological parameters and acid-base status.   









Table 7: Levels in the participation of EMS in uDCD based on the availability of resources 
 
Application Procedure Basic Level 
 
a) Advanced Life Support Ambulances and/or helicopters, electromedical equipment, medication 
and equipment needed for resuscitation.  
b) Possibility of arrival at the receiving hospital within 120 minutes after the PCR. 
c) Communication system with the receiving hospital/donor transplant coordinator.   
d) Specific protocol for uDCD at the EMS.  
e) Training EMS staff in the uDCD protocol.  
f) Regular quality control of the implementation of the uDCD protocol.   
Process Development Level: Donor selection and evaluation optimized and better results achieved. 
a) Support Basic Life Support units in each process.  
b) HIV test strips and drug detection kit.  
c) Mechanical cardiac compressors.   
d) Work- procedures with non-health-care agencies (i.e. police) for locating family members and 
escorting ambulances during donor transfer.  
Optimal Development Level: Optimal performance in donor selection/evaluation and better quality of 
preservation of donor´s organs.  
a) Presence of a second doctor on the scene with a coordinating role with other agencies and 
with the receiving hospital and the Coordination Center.  
b) Presence of a logistics support vehicle at the scene that facilitates the work of cardiac 
massage and provides the necessary material.  
c) Presence of an Emergency Psychologist at the scene, to facilitate the communication with the 
relatives and for the purpose of family care. 
d) Analytical stage, in order to evaluate and correct electrolyte imbalances and consider time of 
cardiac arrest. 























Time of preservation 
(máx.180 min in situ 
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